Pharmacological Validation of NMyristoyltransferase as a Drug Target in Leishmania Donovani

doi 10.1021/acsinfecdis.8b00226.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

A ReplicativeIn VitroAssay for Drug Discovery Against Leishmania Donovani

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Leishmania Donovani and Leishmania Tropica

BMJ
1912English

Leishmania Donovani Triose Phosphate Isomerase: A Potential Vaccine Target Against Visceral Leishmaniasis

PLoS ONE
Multidisciplinary
2012English

Leishmania Donovani in the Peripheral Blood

Experimental Biology and Medicine
MedicineBiochemistryGeneticsMolecular Biology
1923English

Adenine and Adenosine Salvage in Leishmania Donovani

Molecular and Biochemical Parasitology
ParasitologyMolecular Biology
2013English

Wnt5A Signaling Antagonizes Leishmania Donovani Infection

2019English

Role of Aquaglyceroporin (AQP1) Gene and Drug Uptake in Antimony-Resistant Clinical Isolates of Leishmania Donovani

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2008English

Infections by Leishmania Donovani in the Cotton Rat

Journal of General Microbiology
1948English

Validation of PDE5 as a Chemoprevention Target

Cancer Prevention Research
MedicineCancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy